EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients

Liangqiang Li iD, Jing Yu iD, Kunwei Shen iD, Xiaosong Chen iD

Journal of Breast Cancer · 2024 · 27 (3) · 163

DOI: 10.4048/jbc.2023.0248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Cancer, 2024. Verfasst von Liangqiang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Quanzhou City Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Breast NeoplasmsComplianceGenetic TestingPatient Care TeamPrognosis

Autor:innen und Institutionen

  • Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Breast Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
  • Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. chenxiaosong0156@hotmail.com.

ORCID-Profile: Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Education Commission
  • Quanzhou City Science and Technology Program

Zitieren

APA

Li, L., Yu, J., Shen, K., & Chen, X. (2024). The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of Breast Cancer, 27(3), 163. https://doi.org/10.4048/jbc.2023.0248

Vancouver

Li L, Yu J, Shen K, Chen X. The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of Breast Cancer. 2024;27(3):163. doi:10.4048/jbc.2023.0248

BibTeX
@article{Li2024,
  author = {Li, Liangqiang and Yu, Jing and Shen, Kunwei and Chen, Xiaosong},
  title = {The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients},
  journal = {Journal of Breast Cancer},
  year = {2024},
  volume = {27},
  number = {3},
  pages = {163},
  doi = {10.4048/jbc.2023.0248}
}
Kostenlos starten →